Drugs / BNC105
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03647839 | Sep 2018 → Jan 2021 | colorectal cancer | Australasian Gastro-Intestinal Trials Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNC105 | “BNC105 will be provided free of charge by Bionomics, as a sterile solution of BNC105P.” NCT03647839 ↗ |
| Route | Intravenous | “BNC105P is a clear, colorless to yellow liquid presented in a clear glass vial and is intended to be diluted with commercially available sterile 0.9% saline prior to IV administration.” NCT03647839 ↗ |